A case of a pregnant woman with locally advanced cervical esophageal cancer treated with definitive chemoradiotherapy.

Authors :: Tateishi Y
Sakanaka K
Hirashima H
Mukumoto N
Inoo H
Fujii K
Ono T
Nakamura M
Nakata M
Kawasaki K
Tani H
Mandai M
Mizowaki T
Source :: International cancer conference journal [Int Cancer Conf J] 2022 Jul 04; Vol. 11 (4), pp. 292-297. Date of Electronic Publication: 2022 Jul 04 (Print Publication: 2022).
Publication Year :: 2022
Abstract: The information of definitive radiotherapy for a pregnant woman with malignancy was limited; however, it was reported to be potentially feasible with minimal risks. We performed definitive chemoradiotherapy for a pregnant woman with locally advanced cervical esophageal cancer. Feasibility of radiotherapy and safety of fetus were confirmed by the phantom study estimating fetal dose, and monitoring it in each radiotherapy session. The planned chemoradiotherapy completely eradicated esophageal cancer while preserving her laryngopharyngeal function. A female infant was delivered by cesarian section after planned chemoradiotherapy, and she grew without any apparent disorders 2 years after chemoradiotherapy. Chemoradiotherapy might be one of the treatment options for a pregnant woman with cervical esophageal cancer especially wishing the preservation of laryngopharyngeal function.<br />Competing Interests: Conflict of interestThe authors declare that they have no conflict of interest.<br /> (© The Author(s) under exclusive licence to The Japan Society of Clinical Oncology 2022.)

Full Text Access

Tools